Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22


A molecule inducing androgen receptor degradation and selectively targeting prostate cancer cells.

Auvin S, Öztürk H, Abaci YT, Mautino G, Meyer-Losic F, Jollivet F, Bashir T, de Thé H, Sahin U.

Life Sci Alliance. 2019 Aug 20;2(4). pii: e201800213. doi: 10.26508/lsa.201800213. Print 2019 Aug.


Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia.

Lehmann-Che J, Bally C, Letouzé E, Berthier C, Yuan H, Jollivet F, Ades L, Cassinat B, Hirsch P, Pigneux A, Mozziconacci MJ, Kogan S, Fenaux P, de Thé H.

Nat Commun. 2018 May 24;9(1):2047. doi: 10.1038/s41467-018-04384-5.


Publisher Correction: RING tetramerization is required for nuclear body biogenesis and PML sumoylation.

Wang P, Benhenda S, Wu H, Lallemand-Breitenbach V, Zhen T, Jollivet F, Peres L, Li Y, Chen SJ, Chen Z, de Thé H, Meng G.

Nat Commun. 2018 May 4;9(1):1841. doi: 10.1038/s41467-018-04347-w.


RING tetramerization is required for nuclear body biogenesis and PML sumoylation.

Wang P, Benhenda S, Wu H, Lallemand-Breitenbach V, Zhen T, Jollivet F, Peres L, Li Y, Chen SJ, Chen Z, de Thé H, Meng G.

Nat Commun. 2018 Mar 29;9(1):1277. doi: 10.1038/s41467-018-03498-0. Erratum in: Nat Commun. 2018 May 4;9(1):1841.


Detection of Protein SUMOylation In Situ by Proximity Ligation Assays.

Sahin U, Jollivet F, Berthier C, de Thé H, Lallemand-Breitenbach V.

Methods Mol Biol. 2016;1475:139-50. doi: 10.1007/978-1-4939-6358-4_10.


PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence.

Ivanschitz L, Takahashi Y, Jollivet F, Ayrault O, Le Bras M, de Thé H.

Proc Natl Acad Sci U S A. 2015 Nov 17;112(46):14278-83. doi: 10.1073/pnas.1507540112. Epub 2015 Nov 2.


ATL response to arsenic/interferon therapy is triggered by SUMO/PML/RNF4-dependent Tax degradation.

Dassouki Z, Sahin U, El Hajj H, Jollivet F, Kfoury Y, Lallemand-Breitenbach V, Hermine O, de Thé H, Bazarbachi A.

Blood. 2015 Jan 15;125(3):474-82. doi: 10.1182/blood-2014-04-572750. Epub 2014 Nov 13.


Interferon controls SUMO availability via the Lin28 and let-7 axis to impede virus replication.

Sahin U, Ferhi O, Carnec X, Zamborlini A, Peres L, Jollivet F, Vitaliano-Prunier A, de Thé H, Lallemand-Breitenbach V.

Nat Commun. 2014 Jun 19;5:4187. doi: 10.1038/ncomms5187.


Oxidative stress-induced assembly of PML nuclear bodies controls sumoylation of partner proteins.

Sahin U, Ferhi O, Jeanne M, Benhenda S, Berthier C, Jollivet F, Niwa-Kawakita M, Faklaris O, Setterblad N, de Thé H, Lallemand-Breitenbach V.

J Cell Biol. 2014 Mar 17;204(6):931-45. doi: 10.1083/jcb.201305148.


Identification and characterization of multiple novel Rab-myosin Va interactions.

Lindsay AJ, Jollivet F, Horgan CP, Khan AR, Raposo G, McCaffrey MW, Goud B.

Mol Biol Cell. 2013 Nov;24(21):3420-34. doi: 10.1091/mbc.E13-05-0236. Epub 2013 Sep 4.


Mapping the interactions between a RUN domain from DENND5/Rab6IP1 and sorting nexin 1.

Fernandes H, Franklin E, Jollivet F, Bliedtner K, Khan AR.

PLoS One. 2012;7(4):e35637. doi: 10.1371/journal.pone.0035637. Epub 2012 Apr 25.


Synchronization of secretory protein traffic in populations of cells.

Boncompain G, Divoux S, Gareil N, de Forges H, Lescure A, Latreche L, Mercanti V, Jollivet F, Raposo G, Perez F.

Nat Methods. 2012 Mar 11;9(5):493-8. doi: 10.1038/nmeth.1928.


Rab30 is required for the morphological integrity of the Golgi apparatus.

Kelly EE, Giordano F, Horgan CP, Jollivet F, Raposo G, McCaffrey MW.

Biol Cell. 2012 Feb;104(2):84-101. doi: 10.1111/boc.201100080. Epub 2011 Dec 27.


Structural basis for recruitment of Rab6-interacting protein 1 to Golgi via a RUN domain.

Recacha R, Boulet A, Jollivet F, Monier S, Houdusse A, Goud B, Khan AR.

Structure. 2009 Jan 14;17(1):21-30. doi: 10.1016/j.str.2008.10.014.


Analysis of de novo Golgi complex formation after enzyme-based inactivation.

Jollivet F, Raposo G, Dimitrov A, Sougrat R, Goud B, Perez F.

Mol Biol Cell. 2007 Nov;18(11):4637-47. Epub 2007 Sep 12.


Golgi inheritance under a block of anterograde and retrograde traffic.

Nizak C, Sougrat R, Jollivet F, Rambourg A, Goud B, Perez F.

Traffic. 2004 Apr;5(4):284-99.


Characterization of novel Rab6-interacting proteins involved in endosome-to-TGN transport.

Monier S, Jollivet F, Janoueix-Lerosey I, Johannes L, Goud B.

Traffic. 2002 Apr;3(4):289-97.


The human kinesin-like protein RB6K is under tight cell cycle control and is essential for cytokinesis.

Fontijn RD, Goud B, Echard A, Jollivet F, van Marle J, Pannekoek H, Horrevoets AJ.

Mol Cell Biol. 2001 Apr;21(8):2944-55.


Alternative splicing of the human Rab6A gene generates two close but functionally different isoforms.

Echard A, Opdam FJ, de Leeuw HJ, Jollivet F, Savelkoul P, Hendriks W, Voorberg J, Goud B, Fransen JA.

Mol Biol Cell. 2000 Nov;11(11):3819-33.


Characterization of GAPCenA, a GTPase activating protein for Rab6, part of which associates with the centrosome.

Cuif MH, Possmayer F, Zander H, Bordes N, Jollivet F, Couedel-Courteille A, Janoueix-Lerosey I, Langsley G, Bornens M, Goud B.

EMBO J. 1999 Apr 1;18(7):1772-82.


Interaction of a Golgi-associated kinesin-like protein with Rab6.

Echard A, Jollivet F, Martinez O, Lacapère JJ, Rousselet A, Janoueix-Lerosey I, Goud B.

Science. 1998 Jan 23;279(5350):580-5.


Supplemental Content

Loading ...
Support Center